Group | Control | Single | Multiple | P |
---|---|---|---|---|
N | 294 | 366 | 396 | |
Age (years) | 60.63 ± 11.96 | 63.16 ± 12.88 | 65.23 ± 10.93* | 0.113 |
Male(%) | 204 (69.4) | 306 (83.6) | 282 (71.2) | 0.237 |
Smoking(%) | 84 (28.6) | 150 (41.0) | 162 (40.9) | 0.315 |
Hypertension(%) | 168 (57.1) | 216 (59.0) | 276 (69.7) | 0.305 |
Diabetes (%) | 54 (18.4) | 96 (26.2) | 120 (30.3) | 0.345 |
FBG (mmol/L) a | 5.35 (4.39–8.56) | 6.04 (5.32–10.25) | 6.27 (4.28–10.45)* | 0.204 |
Lp(a)(mmol/L) a | 230.39 (112.06–428.32) | 262.12 (121.46–675.28) | 346.55 (176.55–728.36)* | 0.059 |
TC (mmol/L) | 4.40 ± 1.13 | 4.20 ± 0.20 | 4.52 ± 1.28 | 0.291 |
TG (mmol/L) | 1.52 ± 0.97 | 1.51 ± 0.87 | 1.78 ± 0.87 | 0.213 |
LDL-C (mmol/L) | 2.82 ± 0.93 | 2.59 ± 0.84 | 2.88 ± 1.02 | 0.192 |
HDL-C (mmol/L) | 1.17 ± 0.28 | 1.09 ± 0.23 | 1.04 ± 0.26 * | 0.027 |
Lp-PLA2(ng/ml) a | 172.83 (92.35–296.42) | 230.95 (115.69–406.35)* | 289.24 (132.11–430.21)*# | < 0.001 |